Dear Reader,
The legendary quant who built one of Wall Street's most popular buying indicators just announced the #1 stock to buy for 2026.
And for a limited time, he's sharing this new recommendation live on-camera, completely free of charge.
He spent 50 years working alongside legendary investors like George Soros, Michael Steinhardt, Steve Cohen, and Paul Tudor Jones.
His work is coded into every Bloomberg terminal on Wall Street, and is still used by hundreds of banks, brokerages, and hedge funds to this day.
So why is he giving away his #1 buy recommendation for FREE?
It's all comes back to a shocking new market prediction for 2026.
This same legend - who accurately predicted the 2020 covid crash, the 2022 bear market, and the 2023 bank run - is now calling for an abrupt, surprising shift in the U.S. stock market.
The last time this happened, average investors lost over a fifth of their portfolio in just a matter of months.
So I got him to agree to an exclusive sit-down interview, where I got the whole story.
You'll get his #1 buy recommendation for 2026 when you click here.
To pick these recommendations, he consulted the same system that he used when CNBC's Jim Cramer said he'd never bet against him.
So I urge you to take advantage before it's too late.
Go here now to see the names and tickers while you can.
Regards,
Kelly Brown
Host, Chaikin Analytics
Analysts Remain Steadfast on Rocket Lab After Neutron Test Failure
Reported by Ryan Hasson. Article Published: 1/27/2026.
What You Need to Know
- Shares of Rocket Lab have fallen nearly 20% from recent record highs, following a Neutron test failure and uncertainty about its launch schedule.
- Neutron development remains on track, with the setback viewed as routine qualification testing.
- Analysts remain bullish, suggesting the sell-off may reflect short-term uncertainty and profit-taking rather than a change in the long-term outlook.
Shares of Rocket Lab (NASDAQ: RKLB) pulled back sharply over the past week, closing Monday, Jan. 26, nearly 20% below its recent all-time high. The sell-off came despite continued strength across the aerospace and defense sector and a recent successful Electron mission.
As MarketBeat has noted repeatedly, Rocket Lab's long-term valuation depends heavily on the successful development of its medium-lift Neutron rocket. Neutron represents a step change for the company, opening the door to larger payloads, higher-margin missions, and deeper exposure to defense and national security contracts. Unsurprisingly, any Neutron-related headline tends to move the stock sharply.
A U.S. "birthright" claim worth trillions - activated quietly (Ad)
A little-known government process has recently concluded after decades of work, drawing new attention to a significant U.S. resource "claim" that few investors are aware of.
In a new briefing, a market analyst explains what this development involves, why it matters under U.S. law, and how some investors are exploring ways to position themselves early. The presentation focuses on context, implications, and what to understand before taking any action.
That dynamic was on full display on Jan. 21, when Rocket Lab disclosed that a Stage 1 tank ruptured during qualification testing at its Long Beach, California, facility. The market's initial reaction was swift: the stock fell more than 10% in after-hours trading. In the days following the disclosure, the share price failed to sustain a bounce and sold off further from recent highs.
The news and recent price action have likely left some investors wondering whether the incident is overblown, fundamentally alters the program, or is simply a routine part of development testing.
A Routine Setback in Neutron's Development
According to Rocket Lab, the rupture occurred during a hydrostatic pressure test, part of qualification testing designed to push structures beyond their intended operational limits. The company emphasized that such failures are not uncommon during vehicle development and are an intentional part of validating safety margins.
Rocket Lab said no damage occurred to surrounding facilities and that the next Stage 1 tank is already in production. Neutron's development program remains active and ongoing.
What investors are watching now is whether the incident will delay Neutron's maiden flight, currently targeted for the first half of 2026. Rocket Lab did not provide an immediate timing update, saying instead that it will assess the impact and deliver a schedule update during its fourth-quarter 2025 earnings call in February.
For a stock trading near record highs, the absence of near-term clarity was enough to spook momentum-driven holders, at least temporarily.
Progress Continues as Key Hardware Arrives
While headlines focused on the testing failure, Rocket Lab has continued to advance other elements of the Neutron program. The company confirmed that its Hungry Hippo fairing, which has already cleared qualification testing, recently arrived at the Virginia launch site for the Neutron rocket.
Engineers will complete inspections in the coming days before preparing the fairing for additional pre-launch testing at Rocket Lab Launch Complex 3. The delivery underscores that development is progressing on multiple fronts even as individual components go through expected testing hurdles.
Analysts Largely Unfazed by the Sell-Off
Wall Street's reaction has been notably calmer than the market's initial response. Several analysts characterized the test failure as routine and necessary in the context of launch vehicle qualification.
Bank of America reiterated its Buy rating on Rocket Lab and raised its price target to $120 from $60, signaling continued confidence in Neutron's long-term prospects. TD Cowen took a similar view: on Jan. 22 the firm maintained its Buy rating on RKLB and raised its price target to $100 from $60, noting the incident was standard qualification testing rather than a fundamental setback. Analysts also pointed out that no facility damage occurred and replacement hardware is already in production.
Taken together, the pullback appears driven less by any deterioration in Rocket Lab's long-term thesis and more by short-term uncertainty tied to a headline-sensitive catalyst.
With the stock up roughly 1,580% over the past three years, bursts of profit-taking after negative or ambiguous headlines are not unusual, particularly when they involve the company's most critical growth catalyst. As Neutron's development continues and key hardware arrives on site, the recent sell-off may ultimately prove to be more noise than signal.
Investors should watch Rocket Lab's February earnings call for a formal schedule update; until then, the event appears to be a routine — if attention-grabbing — setback in a complex development program.
This email communication is a paid sponsorship from Chaikin Analytics, a third-party advertiser of Earnings360 and MarketBeat.
This ad is sent on behalf of Chaikin Analytics, 201 King Of Prussia Rd., Suite 650, Radnor, PA 19087. If you would like to optout from receiving offers from Chaikin Analytics please click here.
If you need help with your subscription, don't hesitate to email MarketBeat's U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Place #620, Sioux Falls, S.D. 57103. United States of America..